Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality
Objective: Identify Parkinson's disease (PD) clinical subtypes using multi-domain classification; determine subtype symptom progression; assess subtype clinical utility. Background: People with PD present with combinations…Vascular factors in Parkinson’s disease with cognitive impairment
Objective: To review the relationship between vascular related factors and cognitive impairment in Parkinson's disease. Background: Parkinson's disease is a chronic, progressive, neurodegenerative disease that…Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease
Objective: To examine whether PD-MCI patients have increased plasma neurofilament light chain (NfL) levels compared to PD with normal cognition (PD-NC) and healthy controls (HC).…Mental Health Matters Too – Integration of physical and mental health in a multidisciplinary Parkinson’s Clinic
Objective: The overall aim of the project was to demonstrate that people with Parkinson’s disease benefit from good mental health care when mental health services…Clinical outcomes after DBS surgery in cognitively impaired patients with PD
Objective: To describe clinical outcomes after DBS in patients with PD and moderate cognitive impairment (CI). Background: DBS is generally contraindicated in PD patients with…Clinical and nuclear neuroimaging features of Parkinson’s disease with dysphagia
Objective: The clinical and neuroimaging factors associated with dysphagia were investigated in this retrospective data of Parkinson's disease (PD) patients. Background: PD can cause dysphagia…Does age at onset of Parkinson’s disease affect the development of dementia?
Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study
Objective: We aimed to determine how the cognitive domains affect quality of life (QoL) in different cognitive states in PD. Background: Parkinson’s disease with mild…Predictors of transfer to facility or nursing home after discharge of inpatients with Parkinson’s disease: A Japanese single center retrospective study
Objective: To investigate the reasons for hospital admissions for Parkinson's disease (PD) patients and to determine the predictors of transfer to facility or nursing home…Serum microRNA-29 family as potential biomarkers for cognitive impairment in Parkinson’s disease
Objective: To examine whether miRNA-29s (miR-29s) in serum could be used as biomarkers for either Parkinson’s disease with dementia (PDD) or Parkinson’s disease with mild…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 36
- Next Page »